Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

A new study published in The Annals of Thoracic Surgery suggests that Medicaid expansion under the Affordable Care Act has ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

They may take a tissue sample from your tumor (called a biopsy ... other medicines to treat your lung cancer. Ensacove is FDA-approved to treat non-small-cell lung cancer (NSCLC) in adults ...

Ultrasensitive Liquid Biopsy Tech Spots Cancer Earlier Than ... 2024 — The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those ...

In celebration of a decade of powerful advocacy and progress, Rison resident and lung cancer survivor, Melinda McKnight, will travel to Washington, D.C., for the American Lung Association’s 2025 LUNG ...

Enriqueta Felip, MD, PhD, discusses the design of the phase 3 3475A-D77 trial evaluating subcutaneous pembrolizumab in ...

Small-cell lung cancer (SCLC) is the most aggressive type of lung cancer. Each year in the U.S., about 30,000 to 35,000 people are diagnosed with it. For most, it has already spread to distant ...

Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer.

Targeted therapy in metastatic non–small cell lung cancer had a 62% survival advantage ... costs (available from the insurance database). All patients had lung cancer confirmed through biopsy. Data ...

Ryan Nguyen, DO, physician and researcher at the University of Illinois Chicago, emphasizes the transformative impact of immunotherapy in non–small cell lung cancer (NSCLC) and the need for ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.